Financings Roundup

• Pacira Pharmaceuticals Inc., of Parsippany, N.J., priced an underwritten public offering of 6 million shares of common stock at $9.75 per share, a 3.6 percent discount to Wednesday's closing price. The offering will yield gross proceeds of about $58.5 million and will close on or about April 17.